ZA935117B - Anti-feline immunodeficiency virus (FIV) vaccines - Google Patents

Anti-feline immunodeficiency virus (FIV) vaccines

Info

Publication number
ZA935117B
ZA935117B ZA935117A ZA935117A ZA935117B ZA 935117 B ZA935117 B ZA 935117B ZA 935117 A ZA935117 A ZA 935117A ZA 935117 A ZA935117 A ZA 935117A ZA 935117 B ZA935117 B ZA 935117B
Authority
ZA
South Africa
Prior art keywords
fiv
vaccines
immunodeficiency virus
feline immunodeficiency
sequence
Prior art date
Application number
ZA935117A
Other languages
English (en)
Inventor
Albertus Dominicus M Osterhaus
Cornelus Herman Joha Siebelink
Original Assignee
Pitman Moore Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pitman Moore Inc filed Critical Pitman Moore Inc
Publication of ZA935117B publication Critical patent/ZA935117B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA935117A 1992-07-17 1993-07-15 Anti-feline immunodeficiency virus (FIV) vaccines ZA935117B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929215232A GB9215232D0 (en) 1992-07-17 1992-07-17 Vaccines

Publications (1)

Publication Number Publication Date
ZA935117B true ZA935117B (en) 1994-02-08

Family

ID=10718887

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA935117A ZA935117B (en) 1992-07-17 1993-07-15 Anti-feline immunodeficiency virus (FIV) vaccines

Country Status (11)

Country Link
EP (1) EP0651806B1 (de)
JP (2) JPH08500244A (de)
AT (1) ATE166390T1 (de)
AU (1) AU4569293A (de)
DE (1) DE69318716T2 (de)
DK (1) DK0651806T3 (de)
ES (1) ES2118242T3 (de)
GB (1) GB9215232D0 (de)
GR (1) GR3027636T3 (de)
WO (1) WO1994002612A1 (de)
ZA (1) ZA935117B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2234995A (en) * 1994-04-29 1995-11-29 Pharmacia & Upjohn Company Feline immunodeficiency virus vaccine
US5820869A (en) * 1995-06-07 1998-10-13 American Home Products Corporation Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
US5849303A (en) * 1995-06-07 1998-12-15 American Home Products Corporation Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection
US6300118B1 (en) 1995-06-07 2001-10-09 American Home Products Corporation Plasmids comprising a genetically altered feline immunodeficiency virus genome
US7201903B2 (en) 2003-09-11 2007-04-10 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005062053A2 (en) 2003-12-18 2005-07-07 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
WO2005080939A2 (en) 2004-02-19 2005-09-01 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
CA2576902C (en) 2004-06-30 2012-05-08 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP1761556A1 (de) 2004-06-30 2007-03-14 Idexx Laboratories, Inc. Verfahren und vorrichtung zum nachweis des katzen-immunschwäche-virus (fiv) umfassend die verwendung von peptiden, die von der v3-region des fiv-env-proteins abgeleitet sind
US7291338B2 (en) 2005-03-09 2007-11-06 Idexx Laboratories, Inc. Method and device for detecting feline immunodeficiency virus
EP2553452B1 (de) 2010-04-02 2015-03-04 IDEXX Laboratories, Inc. Nachweis des felinen immundefizienzvirus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2669338A1 (fr) * 1990-11-21 1992-05-22 Centre Nat Rech Scient Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline.
US6228608B1 (en) * 1991-02-28 2001-05-08 Aquila Biopharmaceuticals, Inc. Recombinant FIV glycoprotein 160 and P24 gag protein

Also Published As

Publication number Publication date
EP0651806A1 (de) 1995-05-10
GB9215232D0 (en) 1992-09-02
WO1994002612A1 (en) 1994-02-03
DK0651806T3 (da) 1999-01-25
EP0651806B1 (de) 1998-05-20
DE69318716T2 (de) 1998-09-10
ATE166390T1 (de) 1998-06-15
JPH08500244A (ja) 1996-01-16
GR3027636T3 (en) 1998-11-30
DE69318716D1 (de) 1998-06-25
JP2009005706A (ja) 2009-01-15
AU4569293A (en) 1994-02-14
ES2118242T3 (es) 1998-09-16

Similar Documents

Publication Publication Date Title
AU1672388A (en) Expression of human proapolipoprotein a-i
MD430C2 (ro) Procedeu de obţinere a interferonelor leucocitare umane
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
GR3027636T3 (en) Anti-feline immunodeficiency virus (fiv) vaccines.
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
AU697040B2 (en) Retrovirus from the HIV group and its use
HUT52551A (en) Process for production of neutrophil-activizating factor
PL313445A1 (en) Grb3-3 gene, variants thereof and their use
AU7949991A (en) Cloned n-methylhydantoinase
WO1990003394A3 (fr) Nouvelles lymphokines, sequences d'adn codant pour ces lymphokines et compositions pharmaceutiques contenant ces lymphokines
ZA902831B (en) Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by p.falciparum at the sporozoite stage and in the hepatocytes
SU1380209A1 (ru) РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК PUR 291-HAV 22, КОДИРУЮЩАЯ СИНТЕЗ ГИБРИДНОГО ПОЛИПЕПТИДА АНТИГЕННЫХ ДЕТЕРМИНАНТ ВИРУСА ГЕПАТИТА А С β -ГАЛАКТОЗИДАЗОЙ